the current covid 19 situation
play

The current COVID-19 situation and response measures in Republic of - PowerPoint PPT Presentation

The current COVID-19 situation and response measures in Republic of Korea Evolution of COVID-19 in Republic of Korea Jan n 31, , 2020 2020 Tertiary infection Feb 20, 2020 2020 First death case in COVID-19 test Korea March h 19, 2020


  1. The current COVID-19 situation and response measures in Republic of Korea

  2. Evolution of COVID-19 in Republic of Korea Jan n 31, , 2020 2020 Tertiary infection Feb 20, 2020 2020 First death case in COVID-19 test Korea March h 19, 2020 2020 available at local government Dec 31, 2019 Special Entry Feb 19, 2020 2020 Cluster of cases of pneumonia Jan n 30, 2020 2020 Big cluster occur Procedure extended for of unknown origin reported to Feb 21, 2020 2020 all travelers Secondary infection (Shincheonji, China National Health Declare a ‘special Jan n 20, 2020 2020 case Daenam Hopistal) Commission management region’ First confirmed Jan n 23, 2020 2020 March h 5, , 2020 2020 in Daegu, Chengdo Feb 7, , 2020 2020 case in Containment of Declare a ‘special COVID-19 test Korea Wuhan management region’ available at private in Gyeongsan Jan n 28, 2020 2020 Feb 23, 2020 2020 Jan n 20, 2020 2020 Jan n 3, , 2020 2020 Raise up the alert Feb 1, 2020 2020 Raise up the alert Raise up the alert Raise up the alert 1 st Wuhan evacuee level to Orange level to Red level to Yellow level to Blue Feb 12 12, 2020 2020 March h 1, , 2020 2020 March h 12 12, 2020 2020 Expand strict quarantine Establishment of Life Guideline for to HK, Macau Treatment Center high-risk working environment Feb 4, 2020 Focus on treatment of distributed Jan n 12 12, 2020 Jan n 22-23, 23, 2020 Jan n 8, 2020 Jan n 30, 2020 2020 Entry ban on foreigners severe cases 1 st case in Named as 2019-nCoV; 1st Emergency WHO declare with travel history to Whole genome sequence Committee Thailand PHEIC of COVID19 Hubei, China shared with WHO

  3. The number of confirmed cases (as of 27 March) (New) (Total) 1200 10000 9332 Newly confirmed Total confirmed 9000 1000 909 8000 7000 800 686 6000 600 595 600 5000 516 518 483 449 438 4000 427 367 400 3000 253 248 242 207 190 2000 152 200 147 130 131 114 107 104 91 210 98 76748493 87 74 6476 1000 2 3416 3 4 1 3 1 5 3 3 1 110 1 1 1 1 2 100 0 0 1.20 1.22 1.24 1.26 1.28 1.30 2.1 2.3 2.5 2.7 2.9 2.11 2.13 2.15 2.17 2.19 2.21 2.23 2.25 2.27 2.29 3.2 3.4 3.6 3.8 3.10 3.12 3.14 3.16 3.18 3.20 3.22 3.24 3.26

  4. Distribution of confirmed cases (as of 27 March) Male Female Male Female 16 fatality rate CFR = 1.49% 15.2 % 14 36 2000 12 1,374 10 16 8 1,220 6.5 1000 6 29 886 726 25 542 4 7 1,158 369 233 14 2 5 1.8 298 532 444 418 370 5 46 263 261 0.6 130 62 0.1 0.1 0 0.0 0.0 0.0 0 0 0 1 1 Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80 and Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80 and above above All confirmed cases Fatal cases and fatality rate

  5. Distribution by regions and clusters (as of 27 March) 6600 6516 6500 6400 1388 6300 309 (14.9%) 6200 (3.3%) 1283 1300 6100 1200 1100 1000 5079 900 (54.4%) 2556 800 (27.4%) 700 600 500 412 372 400 300 144 200 124 113 91 Shincheonji 46 44 39 41 31 31 100 20 10 8 7 Other clusters 0 Imported cases Under investigation or sporadic cases Distribution by clusters Regional distribution

  6. Response measures along with the progress of outbreaks (as of 25 March) Focus on treatment of severe cases Establishment of Life treatment centers for mild cases Escalation of national alert level to level 4(Red) Designation of special management region for Gyeongsan Designation of special management region for Daegu, Gyeongbuk 742 public health doctors deployed Postpone of the beginning of schools to Mar 9th Social distancing campaign Drive thru sample collection center SOP established Started monitoring of Special Entry Procedure expanded all Shincheonji members to all incoming travelers 2 nd postpone of school opening to Mar 23rd Identification and start of Nationwide check Provincial level case management team 3 rd postpone of the beginning of schools testing for 9,334 members of of psychiatric ward established 7 th update of to April 6th Shincheonji Daegu group case definition 909 Immunofluorescence Assay established Guideline for high risk working Designation of Environment distributed 290 national safe hospitals Designation of 91 national safe hospitals 686 600 595 Testing all incoming travelers Screening tests of all staffs in Cheongdo daenam hospital 518 483 516 Identification of from Europe 449 427 Guro call center cluster 6 th update of case definition 438 367 Special Entry Procedure expanded to Confirmed 31 st case travelers from Europe 253 248 242 related to Shincheonji 190 210 207 152 147 130 131 114 110 107 76 98 76 100 93 87 84 74 74 64 34 16 2 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25

  7. • Capacity : The number of Laboratory Testing Average ca. 15,000/day (as of 25 March) ~ Max. ca. 20,000/day • Turn Around Time: 6 ~ 24hrs 400,000 20,000 New Culmulative 18,199 357,896 18,000 350,000 16,260 16,000 14,753 300,000 13,649 13,526 13,449 14,000 12,950 12,688 12,606 12,603 12,251 12,212 11,863 250,000 11,377 11,292 12,000 10,856 10,845 188,518 10,546 10,329 9,834 9,640 9,411 9,314 200,000 10,000 8,931 8,101 8,100 8,000 6,877 150,000 6,292 6,256 5,982 6,000 4,805 100,000 4,271 4,000 3,012 2,655 50,000 1,750 1,445 2,000 1,146 1,057 1,094 639436853 723 665400252 0 0 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 3. 1 3. 2 3. 3 3. 4 3. 5 3. 6 3. 7 3. 8 3. 9 3. 10 3. 11 3. 12 3. 13 3. 14 3. 15 3. 16 3. 17 3. 18 3. 19 3. 20 3. 21 3. 22 3. 23 3. 24 Testing Institutions (Total 118) : KCDC, National Quarantine Station 4, Research Institutes of Public Health and Environment(RIPHEs) 18, Private medical Laboratories and hospitals 95

  8. Ensuring early patient detection through screening clinics and diagnostic testing - Operation of Drive-Thru Sample Collection & Screening Clinics

  9. Contact tracing strategy : stepwise approach Contact Risk Contacts Investigation classification assessment management • Collective objective • Interview Close Move Contents information  Obtain information contact restriction  Gather additional through patient information interview (identify  Check and verify route) results of the  If necessary, Casual Sx. interview perform preemptive  Perform evaluation contact monitoring defense against for the classification infectious diseases of contacts Method/Tool • Investigate medical records • Interview • Phone location • Perform contacts classification and  Patient information (GPS mobile)  Primary physician management by following guidelines • Card transaction log  Family • CCTV (Closed-Circuit Television)

  10. SMART quarantine information system after MERS outbreak in 2015 National Quarantine station Ministry of foreign affairs KCDC Quarantine process National Health Insurance linked to relevant Corporation Health Insurance institution Review & Ministry of justice Assessment Service

  11. Self Health Check Mobile App Start to Proceed with daily Self Proceed with special quarantine form Check screening clinics Mobile app Health Check

  12. Social distancing campaign As of 23 March For the next 15 days, Avoid physical contact with other people. please participate in enhanced social Put 2- meter “healthy distance” between distancing. yourself and others. Sta tay ho home as as much as as No indoor No religious po poss ssib ible. No night out fitness gathering Cancel or postpone non-essential travel, events, and social gatherings. facilities Hig High-ris risk fa facil ilit ities s ar are stro strongly rec ecommended to to su susp spend op opera ration. Religious facilities, indoor fitness facilities, nightlife venues Venues that remain in operation must strictly comply with the infection prevention guidelines. As of 21 March

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend